Herantis Pharma to Participate in the Upcoming Investor Conferences
Herantis Pharma Plc, Press Release, 3 November 2021 at 12:00 EET Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced that Dr. Craig Cook, Chief Executive Officer, will hold 1x1 meetings and have a company presentation at the following investor conferences: Redeye Life Science Day 2021 - November 11[th ](Virtual) Virtual Presentation at 16:10 – 16:30 EET / 15:10 – 15:30 CET H.C. Wainwright 7th Annual Israel Virtual Conference - November 15, 2021 1x1 meetings and virtual presentation. 8[th]